About Us

The Company was incorporated August 2, 2000, and is a research and development company focused on bringing to the marketplace unique disease-associated biomarkers and in-vitro diagnostic (IVD) tools to fulfill unmet needs in serological assessment of stroke or brain attack. CIS Biotech is primarily engaged in research, development, and marketing of products in the cerebrovascular and cardiovascular disease area and in diabetes.

Business size

1-10 employees


Commercial presence